XBP1 and cancer: In contrast, Xbp1-deficient IECs exhibit increased turnover through NFκB-dependent activation of STAT3, promoting colitis-associated cancer and spontaneous adenomatous polyposis coli (APC)-related tumors in mice (Niederreiter et al. 2013), suggesting that XBP1 might act as a tumor suppressor in the intestine.